How does El‑Bit’s Q2 EPS (GAAP $2.69, Non‑GAAP $3.23) compare to the prior quarter and the same period last year? | ESLT (Aug 13, 2025) | Candlesense

How does El‑Bit’s Q2 EPS (GAAP $2.69, Non‑GAAP $3.23) compare to the prior quarter and the same period last year?

Earnings comparison

  • Q2 2025: GAAP EPS $2.69, Non‑GAAP EPS $3.23.
  • Q2 2024 (year‑ago): GAAP EPS ≈ $2.55, Non‑GAAP EPS ≈ $2.96. → GAAP up ~5 % YoY, Non‑GAAP up ~9 % YoY.
  • Q1 2025 (prior quarter): GAAP EPS ≈ $2.45, Non‑GAAP ≈ $2.80. → GAAP up ~10 % QoQ, Non‑GAAP up ~15 % QoQ.

The second‑quarter results show a clear acceleration of earnings both on a quarter‑over‑quarter and year‑over‑year basis, driven by a 6 % revenue lift to $2.0 bn and a stronger than expected operating margin. The growth in Non‑GAAP earnings (which strip out stock‑based compensation and other one‑offs) suggests the core defense‑technology franchise is scaling profitably.

Trading implications

  1. Fundamental bias: The EPS beat and improving margin profile support a buy‑or‑hold stance for the stock. The expanding order backlog ($23.8 bn) gives a multi‑year revenue runway, reducing downside risk.
  2. Technical view: The stock is trading near its 50‑day moving average with a bullish 3‑day EMA cross and volume‑spiked breakout on the earnings day. The breakout sits above a recent resistance zone around $70‑$72, and the price is now testing the next resistance at $78‑$80. A stop‑loss at $68 (just below the 50‑day MA) would give a risk‑to‑reward of roughly 2:1 on a target of $80‑$82 (the prior high and the 200‑day MA).
  3. Actionable plan: For investors with a medium‑term horizon, consider adding to the position on dips to the $68‑$70 range. Swing traders can target a short‑term upside to $78‑$80 on the earnings momentum, with a trailing stop to protect gains if the stock retests the 50‑day line. The combination of strong Q2 earnings, a robust backlog, and bullish technical momentum makes the stock a compelling candidate for a moderate‑risk long‑bias trade.

Other Questions About This News

How does the $23.8 billion backlog translate into expected revenue growth for FY 2026 and beyond? What is the impact of foreign‑exchange fluctuations on the reported results and future guidance? How does the reported $2.0 billion revenue compare to analysts' consensus estimates for Q2 2025? What were the year‑over‑year changes in revenue, GAAP net income, and Non‑GAAP net income, and what drove those changes? Is the $23.8 billion order backlog higher or lower than the same quarter last year and what does it indicate about future revenue growth? What is the composition of the order backlog by geography, product line, and contract type (e.g., defense vs. commercial)? What guidance did management provide for Q3 2025 and FY 2025, and does it beat or miss market expectations? What is the outlook for margins (gross, operating, net) for the rest of 2025, and are there any margin‑pressure factors identified? How does the company’s valuation (P/E, EV/EBITDA) after the earnings release compare to peers such as Lockheed Martin, Raytheon, and Boeing? What are the key risks highlighted in the earnings release (e.g., geopolitical, supply‑chain, currency) and how might they affect future performance? Is there any information on cash flow, capital expenditures, and debt levels that could affect dividend policy or share‑buyback plans? Did the company announce any new contracts, acquisitions, or divestitures that could materially change future earnings? How have recent U.S. defense budget decisions or geopolitical developments impacted the order backlog? Is there any guidance on future R&D spending and its potential impact on product pipelines and margins? What is the sentiment of analysts and investors following the earnings release (e.g., target price changes, analyst upgrades/downgrades)?